{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:06:19Z","timestamp":1791839179784,"version":"4.3.4"},"reference-count":45,"publisher":"American Society of Hematology","issue":"24","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,11,14]]},"abstract":"<jats:title>Key Points<\/jats:title><jats:p>Obesity is not associated with MGUS or LC-MGUS. High body mass index during midlife is associated with increased risk of progressing from MGUS and LC-MGUS to MM and other LP diseases.<\/jats:p>","DOI":"10.1182\/bloodadvances.2017007609","type":"journal-article","created":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T00:20:43Z","timestamp":1509582043000},"page":"2186-2192","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":74,"title":["Obesity and risk of monoclonal gammopathy of undetermined significance and progression to multiple myeloma: a population-based study"],"prefix":"10.1182","volume":"1","author":[{"given":"Marianna","family":"Thordardottir","sequence":"first","affiliation":[{"name":"Faculty of Medicine, University of Iceland, Reykjavik, Iceland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebba K.","family":"Lindqvist","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrun H.","family":"Lund","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Iceland, Reykjavik, Iceland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"Costello","sequence":"additional","affiliation":[{"name":"Multiple Myeloma Section, National Cancer Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Burton","sequence":"additional","affiliation":[{"name":"Multiple Myeloma Section, National Cancer Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Korde","sequence":"additional","affiliation":[{"name":"Myeloma Service, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sham","family":"Mailankody","sequence":"additional","affiliation":[{"name":"Myeloma Service, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudny","family":"Eiriksdottir","sequence":"additional","affiliation":[{"name":"Icelandic Heart Association, Kopavogur, Iceland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenore J.","family":"Launer","sequence":"additional","affiliation":[{"name":"National Institute on Aging, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilmundur","family":"Gudnason","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Iceland, Reykjavik, Iceland;"},{"name":"Icelandic Heart Association, Kopavogur, Iceland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara B.","family":"Harris","sequence":"additional","affiliation":[{"name":"National Institute on Aging, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Landgren","sequence":"additional","affiliation":[{"name":"Myeloma Service, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigurdur Y.","family":"Kristinsson","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Iceland, Reykjavik, Iceland;"},{"name":"Division of Hematology, Department of Medicine, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2017,11,1]]},"reference":[{"issue":"17","key":"2019111616104364800_B1","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N Engl J Med"},{"issue":"9612","key":"2019111616104364800_B2","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"issue":"9669","key":"2019111616104364800_B3","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0140-6736(09)60318-4","article-title":"Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies","volume":"373","author":"Whitlock","year":"2009","journal-title":"Lancet"},{"issue":"7630","key":"2019111616104364800_B4","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1136\/bmj.39367.495995.AE","article-title":"Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study","volume":"335","author":"Reeves","year":"2007","journal-title":"BMJ"},{"key":"2019111616104364800_B5","first-page":"1","article-title":"Weight control and physical activity","volume-title":"IARC Handbook of Cancer Prevention","author":"International Agency for Research on Cancer","year":"2002"},{"issue":"8","key":"2019111616104364800_B6","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1056\/NEJMsr1606602","article-title":"Body fatness and cancer\u2014viewpoint of the IARC Working Group","volume":"375","author":"Lauby-Secretan","year":"2016","journal-title":"N Engl J Med"},{"issue":"12","key":"2019111616104364800_B7","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"issue":"22","key":"2019111616104364800_B8","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"issue":"22","key":"2019111616104364800_B9","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1182\/blood-2008-12-195008","article-title":"A monoclonal gammopathy precedes multiple myeloma in most patients","volume":"113","author":"Weiss","year":"2009","journal-title":"Blood"},{"key":"2019111616104364800_B10","author":"Swerdlov","year":"2008"},{"issue":"13","key":"2019111616104364800_B11","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance","volume":"354","author":"Kyle","year":"2006","journal-title":"N Engl J Med"},{"issue":"3","key":"2019111616104364800_B12","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1182\/blood-2013-05-505487","article-title":"Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: 728 cases followed up to 30 years in Sweden","volume":"123","author":"Turesson","year":"2014","journal-title":"Blood"},{"issue":"8","key":"2019111616104364800_B13","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N Engl J Med"},{"issue":"9727","key":"2019111616104364800_B14","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0140-6736(10)60482-5","article-title":"Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study","volume":"375","author":"Dispenzieri","year":"2010","journal-title":"Lancet"},{"issue":"2","key":"2019111616104364800_B15","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00277-011-1293-1","article-title":"Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in Germany","volume":"91","author":"Eisele","year":"2012","journal-title":"Ann Hematol"},{"issue":"12","key":"2019111616104364800_B16","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/S0025-6196(11)61089-6","article-title":"Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana","volume":"82","author":"Landgren","year":"2007","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"2019111616104364800_B17","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1182\/blood-2005-08-3449","article-title":"Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States","volume":"107","author":"Landgren","year":"2006","journal-title":"Blood"},{"issue":"4","key":"2019111616104364800_B18","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1182\/blood-2008-12-191676","article-title":"Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden","volume":"114","author":"Landgren","year":"2009","journal-title":"Blood"},{"issue":"7","key":"2019111616104364800_B19","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1182\/blood-2007-10-121285","article-title":"Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders","volume":"111","author":"Brown","year":"2008","journal-title":"Blood"},{"issue":"24","key":"2019111616104364800_B20","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1182\/blood-2011-04-347559","article-title":"Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study","volume":"118","author":"Lindqvist","year":"2011","journal-title":"Blood"},{"issue":"11","key":"2019111616104364800_B21","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1002\/ijc.22968","article-title":"Body mass index and risk of multiple myeloma: a meta-analysis","volume":"121","author":"Larsson","year":"2007","journal-title":"Int J Cancer"},{"issue":"11","key":"2019111616104364800_B22","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.ejca.2011.01.020","article-title":"Body mass index and risk of multiple myeloma: a meta-analysis of prospective studies","volume":"47","author":"Wallin","year":"2011","journal-title":"Eur J Cancer"},{"issue":"2","key":"2019111616104364800_B23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1677\/joe.0.1550191","article-title":"Regional adipocity in man","volume":"155","author":"Arner","year":"1997","journal-title":"J Endocrinol"},{"issue":"11","key":"2019111616104364800_B24","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1093\/annonc\/mdv355","article-title":"Central adiposity, obesity during early adulthood, and pancreatic cancer mortality in a pooled analysis of cohort studies","volume":"26","author":"Genkinger","year":"2015","journal-title":"Ann Oncol"},{"issue":"5","key":"2019111616104364800_B25","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/bjh.12935","article-title":"Body size and multiple myeloma mortality: a pooled analysis of 20 prospective studies","volume":"166","author":"Teras","year":"2014","journal-title":"Br J Haematol"},{"issue":"9","key":"2019111616104364800_B26","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s00256-016-2425-4","article-title":"Abdominal adipose tissue in MGUS and multiple myeloma","volume":"45","author":"Veld","year":"2016","journal-title":"Skeletal Radiol"},{"key":"2019111616104364800_B27","author":"Mittelman","year":"2012"},{"issue":"2","key":"2019111616104364800_B28","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1046\/j.1365-2141.2000.02364.x","article-title":"Insulin-like growth factor induces the survival and proliferation of myeloma cells through an interleukin-6-independent transduction pathway","volume":"111","author":"Ferlin","year":"2000","journal-title":"Br J Haematol"},{"key":"2019111616104364800_B29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev.med.080708.082713","article-title":"Biological mechanisms linking obesity and cancer risk: new perspectives","volume":"61","author":"Roberts","year":"2010","journal-title":"Annu Rev Med"},{"issue":"22","key":"2019111616104364800_B30","doi-asserted-by":"crossref","first-page":"4418","DOI":"10.1182\/blood-2012-06-438606","article-title":"A prospective study of circulating adipokine levels and risk of multiple myeloma","volume":"120","author":"Hofmann","year":"2012","journal-title":"Blood"},{"issue":"22","key":"2019111616104364800_B31","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1182\/blood-2011-01-330407","article-title":"Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease","volume":"118","author":"Fowler","year":"2011","journal-title":"Blood"},{"issue":"7","key":"2019111616104364800_B32","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1182\/blood-2010-01-262394","article-title":"Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women","volume":"116","author":"Landgren","year":"2010","journal-title":"Blood"},{"issue":"7","key":"2019111616104364800_B33","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/leu.2014.34","article-title":"Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey","volume":"28","author":"Landgren","year":"2014","journal-title":"Leukemia"},{"issue":"9","key":"2019111616104364800_B34","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/aje\/kwk115","article-title":"Age, Gene\/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics","volume":"165","author":"Harris","year":"2007","journal-title":"Am J Epidemiol"},{"issue":"3","key":"2019111616104364800_B35","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2005-03-1038","article-title":"Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance","volume":"106","author":"Rajkumar","year":"2005","journal-title":"Blood"},{"issue":"5","key":"2019111616104364800_B36","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group","volume":"121","author":"International Myeloma Working Group","year":"2003","journal-title":"Br J Haematol"},{"issue":"9","key":"2019111616104364800_B37","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/clinchem\/48.9.1437","article-title":"Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains","volume":"48","author":"Katzmann","year":"2002","journal-title":"Clin Chem"},{"key":"2019111616104364800_B38","author":"World Health Organization","year":"2008"},{"issue":"2","key":"2019111616104364800_B39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/174182670200900201","article-title":"Do lipids, blood pressure, diabetes, and smoking confer equal risk of myocardial infarction in women as in men? The Reykjavik Study","volume":"9","author":"J\u00f3nsd\u00f3ttir","year":"2002","journal-title":"J Cardiovasc Risk"},{"issue":"7","key":"2019111616104364800_B40","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3109\/0284186X.2012.698751","article-title":"Data quality at the Icelandic Cancer Registry: comparability, validity, timeliness and completeness","volume":"51","author":"Sigurdardottir","year":"2012","journal-title":"Acta Oncol"},{"key":"2019111616104364800_B41","article-title":"A Language and Environment for Statistical Computing [computer program]","author":"The R Core Team. R","year":"2017"},{"issue":"5","key":"2019111616104364800_B42","doi-asserted-by":"crossref","first-page":"djw264","DOI":"10.1093\/jnci\/djw264","article-title":"Obesity and the transformation of monoclonal gammopathy of undetermined significance to multiple myeloma: a population-based cohort study","volume":"109","author":"Chang","year":"2016","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"2019111616104364800_B43","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.mayocp.2012.06.014","article-title":"Incidence of monoclonal gammopathy of undetermined significance and estimation of duration before first clinical recognition","volume":"87","author":"Therneau","year":"2012","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"2019111616104364800_B44","doi-asserted-by":"crossref","first-page":"859","DOI":"10.4065\/79.7.859","article-title":"Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later","volume":"79","author":"Kyle","year":"2004","journal-title":"Mayo Clin Proc"},{"issue":"suppl 3","key":"2019111616104364800_B45","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1038\/ijo.2008.88","article-title":"Selection of measures in epidemiologic studies of the consequences of obesity","volume":"32","author":"Stevens","year":"2008","journal-title":"Int J Obes (Lond.)"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/1\/24\/2186\/879148\/advances007609.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/1\/24\/2186\/879148\/advances007609.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T23:45:49Z","timestamp":1603237549000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/1\/24\/2186\/16236\/Obesity-and-risk-of-monoclonal-gammopathy-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,1]]},"references-count":45,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2017,11,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2017007609","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,1]]}}}